WHO Collaborating Centre for Global Women's Health, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
Birmingham Medical School, University of Birmingham, Birmingham, UK.
BMJ. 2022 Mar 16;376:e067696. doi: 10.1136/bmj-2021-067696.
To assess the rates of SARS-CoV-2 positivity in babies born to mothers with SARS-CoV-2 infection, the timing of mother-to-child transmission and perinatal outcomes, and factors associated with SARS-CoV-2 status in offspring.
Living systematic review and meta-analysis.
Major databases between 1 December 2019 and 3 August 2021.
Cohort studies of pregnant and recently pregnant women (including after abortion or miscarriage) who sought hospital care for any reason and had a diagnosis of SARS-CoV-2 infection, and also provided data on offspring SARS-CoV-2 status and risk factors for positivity. Case series and case reports were also included to assess the timing and likelihood of mother-to-child transmission in SARS-CoV-2 positive babies.
Two reviewers independently extracted data and assessed study quality. A random effects model was used to synthesise data for rates, with associations reported using odds ratios and 95% confidence intervals. Narrative syntheses were performed when meta-analysis was inappropriate. The World Health Organization classification was used to categorise the timing of mother-to-child transmission (in utero, intrapartum, early postnatal).
472 studies (206 cohort studies, 266 case series and case reports; 28 952 mothers, 18 237 babies) were included. Overall, 1.8% (95% confidence interval 1.2% to 2.5%; 140 studies) of the 14 271 babies born to mothers with SARS-CoV-2 infection tested positive for the virus with reverse transcriptase polymerase chain reaction (RT-PCR). Of the 592 SARS-CoV-2 positive babies with data on the timing of exposure and type and timing of tests, 14 had confirmed mother-to-child transmission: seven in utero (448 assessed), two intrapartum (18 assessed), and five during the early postnatal period (70 assessed). Of the 800 SARS-CoV-2 positive babies with outcome data, 20 were stillbirths, 23 were neonatal deaths, and eight were early pregnancy losses; 749 babies were alive at the end of follow-up. Severe maternal covid-19 (odds ratio 2.4, 95% confidence interval 1.3 to 4.4), maternal death (14.1, 4.1 to 48.0), maternal admission to an intensive care unit (3.5, 1.7 to 6.9), and maternal postnatal infection (5.0, 1.2 to 20.1) were associated with SARS-CoV-2 positivity in offspring. Positivity rates using RT-PCR varied between regions, ranging from 0.1% (95% confidence interval 0.0% to 0.3%) in studies from North America to 5.7% (3.2% to 8.7%) in studies from Latin America and the Caribbean.
SARS-CoV-2 positivity rates were found to be low in babies born to mothers with SARS-CoV-2 infection. Evidence suggests confirmed vertical transmission of SARS-CoV-2, although this is likely to be rare. Severity of maternal covid-19 appears to be associated with SARS-CoV-2 positivity in offspring.
PROSPERO CRD42020178076.
READERS' NOTE: This article is a living systematic review that will be updated to reflect emerging evidence. Updates may occur for up to two years from the date of original publication.
评估 SARS-CoV-2 阳性母亲所生婴儿的 SARS-CoV-2 阳性率、母婴传播的时间和围产期结局,以及与后代 SARS-CoV-2 状态相关的因素。
实时系统评价和荟萃分析。
2019 年 12 月 1 日至 2021 年 8 月 3 日期间的主要数据库。
对因任何原因寻求医院治疗且诊断为 SARS-CoV-2 感染的孕妇和近期孕妇(包括流产或流产后)进行的队列研究,并提供了有关后代 SARS-CoV-2 状态和阳性率危险因素的数据。也纳入了病例系列和病例报告,以评估 SARS-CoV-2 阳性婴儿中母婴传播的时间和可能性。
两名审查员独立提取数据并评估研究质量。使用随机效应模型对率进行综合,使用比值比和 95%置信区间报告关联。当不适合进行荟萃分析时,进行叙述性综合。使用世界卫生组织分类对母婴传播的时间(宫内、分娩期间、产后早期)进行分类。
共纳入 472 项研究(206 项队列研究、266 项病例系列和病例报告;28952 名母亲,18237 名婴儿)。总体而言,14271 名 SARS-CoV-2 阳性母亲所生的 140 项研究中,14271 名婴儿中有 1.8%(95%置信区间 1.2%至 2.5%;140 项研究)的婴儿经逆转录酶聚合酶链反应(RT-PCR)检测出病毒阳性。在 592 名具有暴露时间、检测类型和时间以及结局数据的 SARS-CoV-2 阳性婴儿中,有 14 名确诊为母婴垂直传播:7 例宫内(448 例评估),2 例分娩期间(18 例评估),5 例产后早期(70 例评估)。在 800 名有结局数据的 SARS-CoV-2 阳性婴儿中,20 例为死胎,23 例为新生儿死亡,8 例为早期妊娠丢失;749 例婴儿在随访结束时存活。严重母亲 COVID-19(比值比 2.4,95%置信区间 1.3 至 4.4)、母亲死亡(14.1,4.1 至 48.0)、母亲入住重症监护病房(3.5,1.7 至 6.9)和母亲产后感染(5.0,1.2 至 20.1)与后代 SARS-CoV-2 阳性相关。使用 RT-PCR 的阳性率在不同地区有所不同,从北美研究的 0.1%(95%置信区间 0.0%至 0.3%)到拉丁美洲和加勒比地区研究的 5.7%(3.2%至 8.7%)。
SARS-CoV-2 阳性率在 SARS-CoV-2 阳性母亲所生婴儿中较低。证据表明存在 SARS-CoV-2 的确认垂直传播,但这种情况可能很少见。母亲 COVID-19 的严重程度似乎与后代 SARS-CoV-2 阳性相关。
PROSPERO CRD42020178076。
本文是一篇实时系统评价,将根据新出现的证据进行更新。更新可能会在原始发表日期后的两年内进行。